CAQ-Psychiatry study materials
CAQ-Psychiatry study resources

Hyponatremia and Cognitive Decline in an 82-Year-Old on Paroxetine

CAQ-Psychiatry ยท Put your knowledge to work in context.

All case studies

Hyponatremia and Cognitive Decline in an 82-Year-Old on Paroxetine

An 82-year-old widow is brought by her daughter for 3 months of low mood, 6-kg weight loss, and 'forgetfulness.' She lives alone, has fallen twice in 4 weeks, and now takes her pills erratically. Medications: paroxetine 20 mg daily for 8 years, hydrochlorothiazide 25 mg daily, amlodipine 10 mg, and over-the-counter ibuprofen. She is alert but slow; Mini-Mental State Examination score is 22/30, with deficits in recall and attention. Sodium is 126 mmol/L, potassium 3.4, creatinine 1.1, TSH normal, B12 low-normal. She denies suicidal ideation but says 'everyone would be better off.' Her daughter works full-time and asks whether she needs a nursing home. She has no advance directive.

1. What are the likely contributors to her hyponatremia and cognitive impairment, and what immediate steps do you take?

Read the worked answer

The combination of paroxetine and hydrochlorothiazide is a classic setup for SIADH, especially in an older adult with low weight and recent falls. Sodium 126 mmol/L is moderate-to-severe and symptomatic (confusion, falls), so she needs hospital-level monitoring rather than outpatient adjustment. I would stop hydrochlorothiazide and paroxetine, but not abruptly stop all care; I would check serum osmolality, urine osmolality, urine sodium, TSH, cortisol, and review fluid intake. I would restrict fluids and monitor sodium every 6โ€“12 hours, correcting no faster than 8โ€“10 mmol/L in 24 hours to avoid osmotic demyelination. If she had seizures or severe symptoms, hypertonic saline would be indicated. I would also evaluate depression and cognition after sodium improves, because hyponatremia itself can cause delirium. I would avoid starting another SSRI without monitoring sodium, and I would reassess the need for any antidepressant after the acute phase.

2. How do you distinguish pseudodementia from dementia, and what would change your treatment plan?

Read the worked answer

Pseudodementia is depression-related cognitive impairment: patients may emphasize deficits, give 'don't know' answers, and have relatively preserved orientation, while dementia patients often minimize deficits and confabulate. Her 3-month course, weight loss, and mood symptoms favor depression, but age and vascular risk mean dementia is possible. I would obtain collateral history, a cognitive screen now and after mood treatment, MRI, B12, TSH, and consider neuropsychological testing. If cognition improves with depression treatment, pseudodementia is supported; if deficits persist or progress, I would pursue dementia evaluation. Treatment plan changes: if dementia, I would involve caregiver support, safety assessment for driving, medications, and advance care planning; if depression, I would treat mood and reassess. I would not label dementia during delirium or hyponatremia.

3. How do you address suicide risk, caregiver burden, and disposition?

Read the worked answer

Her statement that 'everyone would be better off' is passive suicidal ideation and requires direct assessment of intent, plan, means, psychosis, and hopelessness. I would ask about firearms and medication stockpiles, involve her daughter, and create a safety plan. Given hyponatremia and falls, she is not safe alone until sodium and cognition improve. I would arrange admission or a supervised setting, then reassess disposition. Caregiver burden is high; the daughter's question about a nursing home should be explored without judgment. I would discuss home health, adult day programs, medication management, and an advance directive. If she lacks decision-making capacity for discharge and refuses safe placement, guardianship may be needed. I would document the capacity assessment and the least restrictive safe option.